Skip to content
AwardedPOLGoods

Leki onkologiczne i ogólne i sprzęt pomocniczy

Published
Published 23 May 2025
Deadline
Closed 24 June 2025

Overview

1) Część nr 1 – Tremelimumab 2) Część nr 2 – Abemaciclibum 3) Część nr 3 – Rucaparyb 4) Część nr 4 – Talqetamab 5) Część nr 5 – Elranatamab 6) Część nr 6 – Enkorafenib i binimetynib 7) Część nr 7 – Avalglucosidasum alfa 8) Część nr 8 – Afliberceptum 9) Część nr 9 – Talazoparibum 10) Część nr 10 – Ewerolimus 11) Część nr 11 – Zawiesina prątka 12) Część nr 12 – Przenośny system infuzyjny

Key details

Country
POL
Status
Awarded
Category
Goods
Procedure
Open
Published
23 May 2025
Deadline
Closed
Classification (CPV)
Antineoplastic agents

Award outcome

Awarded value
PLN 7,907,176
Award date
22 July 2025
Contract period
— → 5 July 2026
Winners
  • Asclepios S.A.
  • AstraZeneca Ktf.
  • Bayer Sp. z o.o. Urtica Sp. z o. o.
  • Pfizer Trading Polska Sp. z o.o.
  • Sanofi Sp. z o.o.
  • Tramco Sp. z o.o.
  • Urtica Sp. z o.o.

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    26 September 2025

  2. Contract Notice

    23 May 2025

Contracting authority

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Leki onkologiczne i ogólne i sprzęt pomocniczy — won by Asclepios S.A. +6 — Skim